Variant Summary
- Also known as
- GLY340LEU,Gly321Leu,G321L
- HGVS
- NC_000009.12:g.130872913_130872914delinsCT,NC_000009.11:g.133748300_133748301delinsCT,NM_005157.6:c.961_962delinsCT,ENST00000318560.6:c.961_962delinsCT,NP_005148.2:p.Gly321Leu,ENSP00000323315.5:p.Gly321Leu
- Variant Type(s)
- coding_sequence_variant
- Evidence Items
- 1
Evidence Level Distribution
Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = ABL1 and variant = G340L.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Dasatinib,Imatinib Mesylate | 3 |